Julia Hoefer

1.0k total citations
18 papers, 828 citations indexed

About

Julia Hoefer is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, Julia Hoefer has authored 18 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Genetics and 6 papers in Oncology. Recurrent topics in Julia Hoefer's work include Prostate Cancer Treatment and Research (10 papers), Estrogen and related hormone effects (6 papers) and Cancer, Lipids, and Metabolism (4 papers). Julia Hoefer is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Estrogen and related hormone effects (6 papers) and Cancer, Lipids, and Metabolism (4 papers). Julia Hoefer collaborates with scholars based in Austria, Germany and Netherlands. Julia Hoefer's co-authors include Zoran Čulig, Martin Puhr, Helmut Klocker, Isabel Heidegger, Holger H.H. Erb, Georg Schäfer, Hannes Neuwirt, Florian Handle, Su Jung Oh and Iris E. Eder and has published in prestigious journals such as PLoS ONE, Oncogene and Clinical Cancer Research.

In The Last Decade

Julia Hoefer

18 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Hoefer Austria 14 416 333 272 268 119 18 828
Simeng Wen China 17 559 1.3× 310 0.9× 407 1.5× 224 0.8× 59 0.5× 30 933
Walid J. Azar Australia 11 480 1.2× 190 0.6× 262 1.0× 254 0.9× 181 1.5× 11 827
Lizamma Antony United States 15 519 1.2× 441 1.3× 122 0.4× 230 0.9× 122 1.0× 20 901
Peter Hammarsten Sweden 19 482 1.2× 433 1.3× 273 1.0× 261 1.0× 86 0.7× 27 1.2k
Lacey M. Litchfield United States 18 557 1.3× 225 0.7× 454 1.7× 309 1.2× 47 0.4× 37 962
Dongrong Yang China 21 654 1.6× 274 0.8× 423 1.6× 235 0.9× 61 0.5× 54 1.2k
Stefan Preković Netherlands 16 678 1.6× 492 1.5× 276 1.0× 348 1.3× 161 1.4× 48 1.3k
Clay E.S. Comstock United States 18 735 1.8× 451 1.4× 290 1.1× 363 1.4× 68 0.6× 22 1.2k
Youngtae Jeong United States 11 504 1.2× 154 0.5× 199 0.7× 190 0.7× 50 0.4× 20 805
Bekir Cinar United States 22 686 1.6× 424 1.3× 255 0.9× 223 0.8× 134 1.1× 29 1.3k

Countries citing papers authored by Julia Hoefer

Since Specialization
Citations

This map shows the geographic impact of Julia Hoefer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Hoefer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Hoefer more than expected).

Fields of papers citing papers by Julia Hoefer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Hoefer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Hoefer. The network helps show where Julia Hoefer may publish in the future.

Co-authorship network of co-authors of Julia Hoefer

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Hoefer. A scholar is included among the top collaborators of Julia Hoefer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Hoefer. Julia Hoefer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Eigentler, Andrea, Florian Handle, Hubert Hackl, et al.. (2023). Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts. Oncogene. 43(4). 235–247. 12 indexed citations
2.
Puhr, Martin, Andrea Eigentler, Florian Handle, et al.. (2021). Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer. Oncogene. 40(17). 3087–3100. 26 indexed citations
3.
Hoefer, Julia, et al.. (2020). The ‘rejuvenating factor’ TIMP‐2 is detectable in human blood components for transfusion. Vox Sanguinis. 116(5). 533–539. 3 indexed citations
4.
Handle, Florian, Martin Puhr, Georg Schaefer, et al.. (2018). The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models. Molecular Cancer Therapeutics. 17(12). 2722–2731. 36 indexed citations
5.
Puhr, Martin, Julia Hoefer, Andrea Eigentler, et al.. (2017). The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy. Clinical Cancer Research. 24(4). 927–938. 129 indexed citations
6.
Hoefer, Julia, et al.. (2017). The “Aging Factor” Eotaxin-1 (CCL11) Is Detectable in Transfusion Blood Products and Increases with the Donor’s Age. Frontiers in Aging Neuroscience. 9. 402–402. 36 indexed citations
7.
Handle, Florian, Holger H.H. Erb, Birgit Luef, et al.. (2016). SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells. Molecular Cancer Research. 14(6). 574–585. 36 indexed citations
8.
Hoefer, Julia, Florian Handle, Martin Puhr, et al.. (2016). Critical Role of Androgen Receptor Level in Prostate Cancer Cell Resistance to New Generation Antiandrogen Enzalutamide. Endocrine Abstracts. 1 indexed citations
9.
Hoefer, Julia, Florian Handle, Martin Puhr, et al.. (2016). Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide. Oncotarget. 7(37). 59781–59794. 46 indexed citations
10.
Puhr, Martin, Julia Hoefer, Andrea Eigentler, et al.. (2015). PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer. Oncogene. 35(18). 2322–2332. 39 indexed citations
11.
Tancevski, Ivan, Manfred Nairz, Andrea Schroll, et al.. (2014). Fibrates ameliorate the course of bacterial sepsis by promoting neutrophil recruitment via CXCR 2. EMBO Molecular Medicine. 6(6). 810–820. 28 indexed citations
12.
Puhr, Martin, Julia Hoefer, Hannes Neuwirt, et al.. (2014). PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells. Oncotarget. 5(23). 12043–12056. 30 indexed citations
13.
Hoefer, Julia, Johann Kern, Iris E. Eder, et al.. (2013). SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer. Endocrine Related Cancer. 21(2). 175–187. 41 indexed citations
14.
Hoefer, Julia, Georg Schäfer, Helmut Klocker, et al.. (2012). PIAS1 Is Increased in Human Prostate Cancer and Enhances Proliferation through Inhibition of p21. American Journal Of Pathology. 180(5). 2097–2107. 69 indexed citations
15.
Puhr, Martin, Julia Hoefer, Georg Schäfer, et al.. (2012). Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205. American Journal Of Pathology. 181(6). 2188–2201. 211 indexed citations
16.
Shariat, Shahrokh F., Thomas Chromecki, Julia Hoefer, et al.. (2011). Soluble gp130 Regulates Prostate Cancer Invasion and Progression in an Interleukin-6 Dependent and Independent Manner. The Journal of Urology. 186(5). 2107–2114. 13 indexed citations
17.
Tancevski, Ivan, Egon Demetz, Kathrin Eller, et al.. (2010). The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice. PLoS ONE. 5(1). e8722–e8722. 43 indexed citations
18.
Tancevski, Ivan, Andreas Wehinger, Egon Demetz, et al.. (2008). The thyromimetic T-0681 protects from atherosclerosis. Journal of Lipid Research. 50(5). 938–944. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simeng Wen Breakdown of academic impact, for papers by Walid J. Azar Breakdown of academic impact, for papers by Lizamma Antony Breakdown of academic impact, for papers by Peter Hammarsten Breakdown of academic impact, for papers by Lacey M. Litchfield Breakdown of academic impact, for papers by Dongrong Yang Breakdown of academic impact, for papers by Stefan Preković Breakdown of academic impact, for papers by Clay E.S. Comstock Breakdown of academic impact, for papers by Youngtae Jeong Breakdown of academic impact, for papers by Bekir Cinar
Rankless by CCL
2026